tert-Butyl 1-(2-methoxyethyl)piperidin-4-ylcarbamate, 95.0%, 1g

(R)-2-(((Benzyloxy)carbonyl)amino)-3-(1-(tert-butoxycarbonyl)piperidin-4-yl)propanoic acid, 98%, 250mg

(2-OXO-1,3-DIOXOLAN-4-YL)METHYL METHACRYLATE, 95.0%, 25g

Round Bottom Flask 1N 12000ml 55/50, 1ea

Tofacitinib metabolite-1, 5mg

(S)-3-Boc-Amino-butylamine hydrochloride, 97.0%, 1g

ETHYL 7-OXO-4,5,6,7-TETRAHYDROBENZOFURAN-6-CARBOXYLATE, 95.0%, 500mg

(3S)-(+)-1-Benzyl-3-(ethylamino)pyrrolidine>95.0%(GC)5g

4,6-Dihydroxyisophthalic acid, 95.0%, 25g

(1R,4S)-4-((tert-Butoxycarbonyl)amino)cyclopent-2-enecarboxylic acid, 95.0%, 10g

(6-Chloro-5-fluoropyridin-3-yl)boronic acid, 95.0%, 1g

5-METHOXY-1H-BENZO[D][1,3]OXAZINE-2,4-DIONE, 95.0%, 10g

4-Biphenylthiocarboxamide, 250mg